
Lineage Cell Therapeutics, Inc.
LCTXNYSECIK 876343HealthcareFiscal year ends Dec 31
Reports and events: 623 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0916:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040058 |
| 2023-11-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040057 |
| 2023-09-0717:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-031993 |
| 2023-08-1016:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027552 |
| 2023-08-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027545 |
| 2023-07-2716:05 ET | DEF 14A | Proxy statementPeriod 2023-07-27 | 0001493152-23-025680 |
| 2023-06-2117:00 ET | 8-K | 8.01 Other events | 0001493152-23-022030 |
| 2023-05-1817:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-018160 |
| 2023-05-1116:15 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016392 |
| 2023-05-1116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-016388 |
| 2023-04-2716:15 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001493152-23-013813 |
| 2023-03-0916:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-007129 |
| 2023-03-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-007127 |
| 2023-01-2308:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-002127 |
| 2022-11-1016:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-031359 |
| 2022-11-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-031351 |
| 2022-10-3108:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-029913 |
| 2022-10-2817:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001493152-22-029887 |
| 2022-09-3017:00 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001493152-22-027295 |
| 2022-09-2617:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-026840 |
| 2022-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022085 |
| 2022-08-1116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-022077 |
| 2022-07-0716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-018802 |
| 2022-06-1716:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-22-017162 |
| 2022-05-1216:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013041 |
| 2022-05-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-013033 |
| 2022-05-1219:54 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-012893 |
| 2022-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2022-04-29 | 0001493152-22-011552 |
| 2022-03-2517:23 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-22-002416 |
| 2022-03-1016:37 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-006520 |
| 2022-03-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-006506 |
| 2022-02-1409:00 ET | 8-K | 8.01 Other events | 0001493152-22-004309 |
| 2021-12-2106:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-032109 |
| 2021-12-2006:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-031964 |
| 2021-12-1316:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-031281 |
| 2021-11-1016:16 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-027859 |
| 2021-11-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-027855 |
| 2021-09-3017:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-024236 |
| 2021-09-1507:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-21-022765 |
| 2021-08-1216:21 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-019518 |
| 2021-08-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-019506 |
| 2021-08-0317:00 ET | DEF 14A | Proxy statementPeriod 2021-08-03 | 0001493152-21-018445 |
| 2021-07-2117:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-21-017458 |
| 2021-06-1607:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-21-014503 |
| 2021-06-0107:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-013294 |
| 2021-05-1316:21 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-011299 |
| 2021-05-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-011290 |
| 2021-05-0517:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-21-010533 |
| 2021-05-0317:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-010348 |
| 2021-04-2217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-21-009474 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.